TrialBreast cancer research : BCR2010

Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial.

Christos Markopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.